Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile

This publication has 92 references indexed in Scilit:

• Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine
  European journal of pain, 2009
• Efficacy and Safety of Transdermal Buprenorphine: A Randomized, Placebo-Controlled Trial in 289 Patients with Severe Cancer Pain
  Journal of Pain and Symptom Management, 2008
• Examination of the preclinical antinociceptive efficacy of buprenorphine and its designation as full- or partial-agonist
  Acute Pain, 2007
• Long-term management of chronic pain with transdermal buprenorphine: A multicenter, open-label, follow-up study in patients from three short-term clinical trials
  Clinical Therapeutics, 2006
• Transdermal buprenorphine in clinical practice – a post‐marketing surveillance study in 13 179 patients
  Current Medical Research and Opinion, 2005
• Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain
  European Journal of Pharmacology, 2005
• Transdermal buprenorphine in the treatment of chronic pain: Resultsof a phase III, multicenter, randomized, double-blind, placebo-controlled study
  Clinical Therapeutics, 2004
• G-Protein Coupling and Efficacy of Mu-Opioid Agonists: Relationship to Behavioral Efficacy
  Reviews in Analgesia, 2004
• Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study
  The Pain Clinic, 2003
• Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: A multicenter, randomized, double-blind, placebo-controlled trial
  Clinical Therapeutics, 2003